Entering text into the input field will update the search result below

Premarket analyst action - healthcare

  • Cara Therapeutics (NASDAQ:CARA) resumed with Buy rating and $22 (53% upside) price target at H.C. Wainwright.
  • Mirati Therapeutics (NASDAQ:MRTX) initiated with Overweight rating and $44 (27% upside) price target at Barclays.
  • Fennec Pharmaceuticals (NASDAQ:FENC) initiated with Outperform rating and $17 (81% upside) price target at Wedbush.
  • Motus GI Holdings (NASDAQ:MOTS) initiated with Outperform rating and $7 (40% upside) price target at Oppenheimer.
  • Taro Pharmaceutical Industries (NYSE:TARO) initiated with Buy rating and $124 (24% upside) price target at H.C. Wainwright.
  • Genfit SA (OTCPK:GNFTF) initiated with Buy rating and €105 price target at H.C. Wainwright.
  • Otonomy (NASDAQ:OTIC) upgraded to Overweight at Piper Jaffray.
  • Aratana Therapeutics (NASDAQ:PETX) upgraded to Buy at CL King.
  • Express Scripts (NASDAQ:ESRX) upgraded to Market Perform at Bernstein.
  • Voyager Therapeutics (NASDAQ:VYGR) downgraded to Neutral at Wedbush. Downgraded to In-line at Evercore ISI.
  • Denali Therapeutics (NASDAQ:DNLI) downgraded to In-line at Evercore ISI.
  • REGENXBIO (NASDAQ:RGNX) downgraded to In-line at Evercore ISI.

Recommended For You

About CARA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CARA--
Cara Therapeutics, Inc.